Will Market Access as we know it, undergo a fundamental shift – moving away from company-centered and towards patient-centered? This article identifies several forces that challenge the current understanding of market access and lobbies for a patient-centered, comprehensive approach that aims to address the needs of all stakeholders, but primarily create value for patients: Patient Access. Read more here. (Source: John Glasspool, PharmExec.com, 9/20/14).
You are here: / / Is This The End Of Market Access, As We Know It?